Should I stop or should I go on? Disease modifying therapy after the first clinical episode of multiple sclerosis.

Tobias MonscheinSabine Salhofer-PolanyiPatrick AltmannTobias ZrzavyAssunta Dal-BiancoGabriel BstehPaulus RommerThomas BergerFritz Leutmezer

Published in: Journal of neurology (2020)

In CIS patients with immediate DMT after their first clinical episode, older age at the time of DMT discontinuation is the main predictive factor for sustained NEDA status.

Keyphrases

multiple sclerosis
physical activity
stem cells
middle aged
community dwelling